|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein]; thymoquinone inhibits the reaction [Cytarabine results in increased activity of ACHE protein] |
CTD |
PMID:27206696 PMID:36419121 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Ethanol results in increased expression of ACTA2 protein]; thymoquinone inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of ACTA2 mRNA]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:27375216 PMID:27688165 PMID:31935363 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of ACTG2 mRNA] |
CTD |
PMID:38504479 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Ada |
adenosine deaminase |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased activity of ADA protein] |
CTD |
PMID:36193556 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
decreases expression |
ISO |
thymoquinone results in decreased expression of ADAM17 protein |
CTD |
PMID:36558177 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of AFP protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein alternative form]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein] |
CTD |
PMID:24012840 PMID:29923357 PMID:35437842 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
thymoquinone results in increased expression of AIFM1 protein |
CTD |
PMID:29981725 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
thymoquinone results in decreased phosphorylation of AKT1 protein thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:31298468 PMID:36193556 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT2 protein] |
CTD |
PMID:36193556 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Malathion results in increased activity of ALPL protein] |
CTD |
PMID:33510276 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APP protein alternative form]; thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APP protein] |
CTD |
PMID:28734741 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of AR protein] |
CTD |
PMID:36506574 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
thymoquinone results in increased expression of ATF4 mRNA; thymoquinone results in increased expression of ATF4 protein |
CTD |
PMID:29981725 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
thymoquinone results in increased expression of ATF6 mRNA; thymoquinone results in increased expression of ATF6 protein |
CTD |
PMID:29981725 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
thymoquinone results in decreased expression of ATG12 protein |
CTD |
PMID:31298468 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg5 |
autophagy related 5 |
decreases expression |
ISO |
thymoquinone results in decreased expression of ATG5 protein |
CTD |
PMID:31298468 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
decreases expression |
ISO |
thymoquinone results in decreased expression of ATG7 protein |
CTD |
PMID:31298468 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression |
ISO |
thymoquinone results in decreased expression of BAD protein |
CTD |
PMID:34173702 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
thymoquinone affects the reaction [Ethanol affects the expression of BAX mRNA]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA]; thymoquinone inhibits the reaction [Ethanol results in increased expression of BAX protein]; thymoquinone inhibits the reaction [sodium arsenate results in increased expression of BAX mRNA]; thymoquinone inhibits the reaction [sodium arsenate results in increased expression of BAX protein]; thymoquinone inhibits the reaction [sodium arsenite results in increased expression of BAX protein] thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein] [Benzo(a)pyrene co-treated with thymoquinone] results in increased expression of BAX mRNA; thymoquinone results in increased expression of and affects the localization of BAX protein thymoquinone results in increased expression of BAX protein |
CTD |
PMID:24289642 PMID:29085585 PMID:29710533 PMID:29981725 PMID:30558456 PMID:31433961 PMID:34627931 PMID:35437842 PMID:36193556 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
thymoquinone results in decreased expression of BCL2 protein thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] [Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of BCL2 mRNA; DDIT3 protein affects the reaction [thymoquinone results in decreased expression of BCL2 protein] thymoquinone affects the reaction [Ethanol affects the expression of BCL2 mRNA]; thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; thymoquinone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]; thymoquinone inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA]; thymoquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:21609759 PMID:24289642 PMID:29085585 PMID:29710533 PMID:29923357 PMID:29981725 PMID:30558456 PMID:31298468 PMID:31433961 PMID:35437842 PMID:36193556 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of BCL2L1 protein thymoquinone inhibits the reaction [Bleomycin results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:29981725 PMID:31433961 PMID:34627931 PMID:34818114 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
thymoquinone results in decreased expression of BID protein |
CTD |
PMID:31298468 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression multiple interactions |
ISO EXP |
thymoquinone results in decreased expression of BIRC5 protein thymoquinone inhibits the reaction [Malathion results in increased expression of BIRC5 protein] Doxorubicin promotes the reaction [thymoquinone results in decreased expression of BIRC5 protein]; thymoquinone promotes the reaction [Doxorubicin results in decreased expression of BIRC5 protein] |
CTD |
PMID:31433961 PMID:33510276 PMID:34605108 PMID:34627931 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein] |
CTD |
PMID:31935363 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
decreases expression |
ISO |
thymoquinone results in decreased expression of CASP12 protein |
CTD |
PMID:29981725 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity increases cleavage |
ISO EXP |
thymoquinone results in increased expression of CASP3 protein modified form Doxorubicin promotes the reaction [thymoquinone results in increased activity of CASP3 protein]; thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of CASP3 protein]; thymoquinone promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] thymoquinone results in increased cleavage of CASP3 protein thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]; thymoquinone inhibits the reaction [nonylphenol results in increased expression of CASP3 protein]; thymoquinone inhibits the reaction [Propylthiouracil results in increased expression of CASP3 protein]; thymoquinone inhibits the reaction [sodium arsenate results in increased cleavage of CASP3 protein]; thymoquinone inhibits the reaction [sodium arsenate results in increased expression of CASP3 mRNA]; thymoquinone inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; [[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased cleavage of CASP3 protein; [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [thymoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP3 protein modified form]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [thymoquinone results in increased activity of CASP3 protein]; DDIT3 protein affects the reaction [thymoquinone results in increased activity of and results in increased cleavage of CASP3 protein]; MAPK14 protein promotes the reaction [[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased cleavage of CASP3 protein]; MAPK3 protein inhibits the reaction [thymoquinone results in increased expression of CASP3 protein modified form]; thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CASP3 protein]; thymoquinone results in increased activity of and results in increased cleavage of CASP3 protein |
CTD |
PMID:29085585 PMID:29710533 PMID:29981725 PMID:30558456 PMID:31298468 PMID:31433961 PMID:31935363 PMID:34173702 PMID:34234489 PMID:34605108 PMID:34627931 PMID:35437842 PMID:36176197 PMID:36193556 PMID:37466128 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression multiple interactions increases cleavage |
ISO |
thymoquinone results in increased expression of CASP7 protein modified form Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP7 protein modified form] |
CTD |
PMID:29981725 PMID:31433961 PMID:34627931 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP8 protein] |
CTD |
PMID:29085585 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression increases activity multiple interactions increases cleavage |
ISO EXP |
thymoquinone results in increased expression of CASP9 protein modified form thymoquinone results in increased activity of CASP9 protein Doxorubicin promotes the reaction [thymoquinone results in increased activity of CASP9 protein]; thymoquinone promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] thymoquinone results in increased cleavage of CASP9 protein thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP9 protein] Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP9 protein modified form] |
CTD |
PMID:29085585 PMID:29981725 PMID:31298468 PMID:31433961 PMID:34605108 PMID:34627931 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP ISO |
thymoquinone results in increased activity of CAT protein thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of CAT mRNA]; thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [cyhalothrin results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT mRNA]; thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of CAT mRNA]; thymoquinone inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Thioacetamide results in decreased activity of CAT protein] |
CTD |
PMID:10755708 PMID:20957680 PMID:20972371 PMID:21382363 PMID:22450443 PMID:26645134 PMID:27206696 PMID:28734741 PMID:29923357 PMID:30558456 PMID:33832332 PMID:34234489 PMID:35437842 PMID:36193556 PMID:38504479 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
thymoquinone results in decreased expression of CCNB1 protein |
CTD |
PMID:32112862 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO EXP |
thymoquinone results in decreased expression of CCND1 mRNA; thymoquinone results in decreased expression of CCND1 protein Doxorubicin promotes the reaction [thymoquinone results in decreased expression of CCND1 protein]; thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased expression of CCND1 protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased expression of CCND1 protein] thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] [Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of CCND1 mRNA; Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND1 protein] |
CTD |
PMID:24012840 PMID:24289642 PMID:31433961 PMID:32112862 PMID:34605108 PMID:34627931 PMID:36193556 More...
|
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND2 protein] |
CTD |
PMID:34627931 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of CCND3 protein Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND3 protein] |
CTD |
PMID:32112862 PMID:34627931 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CCNE1 protein] |
CTD |
PMID:24012840 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CD14 protein] |
CTD |
PMID:31935363 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
thymoquinone results in decreased expression of CD44 protein |
CTD |
PMID:31298468 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdh1 |
cadherin 1 |
increases expression multiple interactions |
ISO |
thymoquinone results in increased expression of CDH1 protein CTNNB1 protein inhibits the reaction [thymoquinone results in increased expression of CDH1 protein]; Lithium Chloride inhibits the reaction [thymoquinone results in increased expression of CDH1 protein]; thymoquinone promotes the reaction [cordycepin results in increased expression of CDH1 protein]; XAV939 promotes the reaction [thymoquinone results in increased expression of CDH1 protein] |
CTD |
PMID:32112862 PMID:35774120 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of CDH2 protein CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of CDH2 protein]; Lithium Chloride inhibits the reaction [thymoquinone results in decreased expression of CDH2 protein]; thymoquinone promotes the reaction [cordycepin results in decreased expression of CDH2 protein]; XAV939 promotes the reaction [thymoquinone results in decreased expression of CDH2 protein] |
CTD |
PMID:32112862 PMID:35774120 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
thymoquinone results in decreased expression of CDK2 protein |
CTD |
PMID:32112862 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of CDK4 protein] |
CTD |
PMID:24012840 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP ISO |
thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] [Benzo(a)pyrene co-treated with thymoquinone] results in increased expression of CDKN1A mRNA |
CTD |
PMID:24012840 PMID:24289642 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of CEACAM20 protein Doxorubicin promotes the reaction [thymoquinone results in decreased expression of CEACAM20 protein]; thymoquinone promotes the reaction [Doxorubicin results in decreased expression of CEACAM20 protein] |
CTD |
PMID:34605108 |
|
NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
[Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of CHUK mRNA |
CTD |
PMID:24289642 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO EXP |
thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] thymoquinone inhibits the reaction [Thioacetamide results in increased expression of COL1A1 mRNA] thymoquinone inhibits the reaction [Ethanol results in increased expression of COL1A1 protein]; thymoquinone inhibits the reaction [Paraquat results in increased expression of COL1A1 mRNA]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of COL1A1 mRNA] |
CTD |
PMID:27375216 PMID:27688165 PMID:31935363 PMID:38504479 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Paraquat results in increased expression of COL4A1 mRNA] |
CTD |
PMID:27375216 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression multiple interactions |
ISO EXP |
thymoquinone results in decreased expression of CTNNB1 protein thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of CTNNB1 mRNA] CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of CDH2 protein]; CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of MMP2 protein]; CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of VIM protein]; CTNNB1 protein inhibits the reaction [thymoquinone results in increased expression of CDH1 protein]; Lithium Chloride inhibits the reaction [thymoquinone results in decreased expression of and results in increased phosphorylation of CTNNB1 protein]; thymoquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CTNNB1 protein]; thymoquinone results in decreased expression of and results in increased phosphorylation of and results in decreased activity of CTNNB1 protein; XAV939 promotes the reaction [thymoquinone results in decreased expression of and results in increased phosphorylation of CTNNB1 protein] thymoquinone results in decreased expression of CTNNB1 mRNA |
CTD |
PMID:32112862 PMID:34234489 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
thymoquinone results in increased expression of CXCR4 mRNA |
CTD |
PMID:31812774 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression multiple interactions |
ISO |
thymoquinone results in increased expression of CYCS protein thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of CYCS protein] |
CTD |
PMID:31433961 PMID:36193556 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] |
CTD |
PMID:36193556 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP2E1 protein] |
CTD |
PMID:35437842 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of DDIT3 protein]; DDIT3 protein affects the reaction [thymoquinone results in decreased expression of BCL2 protein]; DDIT3 protein affects the reaction [thymoquinone results in increased activity of and results in increased cleavage of CASP3 protein]; DDIT3 protein affects the reaction [thymoquinone results in increased cleavage of PARP1 protein] thymoquinone inhibits the reaction [Doxorubicin results in increased expression of DDIT3 protein] thymoquinone results in increased expression of DDIT3 mRNA; thymoquinone results in increased expression of DDIT3 protein |
CTD |
PMID:29981725 PMID:34392583 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Rotenone results in increased expression of DNM1L protein] |
CTD |
PMID:28526446 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
thymoquinone results in increased expression of EIF2AK3 protein |
CTD |
PMID:29981725 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Carbon Tetrachloride results in decreased expression of EPHX1 mRNA] |
CTD |
PMID:21994235 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
ISO |
thymoquinone results in increased expression of ERN1 mRNA; thymoquinone results in increased expression of ERN1 protein |
CTD |
PMID:29981725 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of FOS mRNA] |
CTD |
PMID:29923357 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Bleomycin results in increased expression of FSHB protein] |
CTD |
PMID:34818114 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity multiple interactions |
EXP |
thymoquinone results in increased activity of G6PD protein thymoquinone inhibits the reaction [Cisplatin results in decreased activity of G6PD protein] |
CTD |
PMID:33832332 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [nonylphenol results in increased expression of GFAP protein] |
CTD |
PMID:37466128 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO EXP |
thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased activity of GGT1 protein] thymoquinone inhibits the reaction [Thioacetamide results in increased activity of GGT1 protein] |
CTD |
PMID:36193556 PMID:38504479 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Malathion results in increased activity of GOT1 protein] |
CTD |
PMID:33510276 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpc3 |
glypican 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of GPC3 protein] |
CTD |
PMID:35437842 |
|
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased activity of GPT protein]; thymoquinone inhibits the reaction [Cisplatin results in increased activity of GPT protein]; thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein]; thymoquinone inhibits the reaction [Ethanol results in increased activity of GPT protein]; thymoquinone inhibits the reaction [Malathion results in increased activity of GPT protein]; thymoquinone inhibits the reaction [Thioacetamide results in increased activity of GPT protein] |
CTD |
PMID:29085585 PMID:29923357 PMID:33510276 PMID:33832332 PMID:35437842 PMID:38504479 More...
|
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP ISO |
thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of GPX1 mRNA] thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased activity of GPX1 protein] |
CTD |
PMID:28734741 PMID:36193556 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation multiple interactions |
ISO EXP |
thymoquinone results in decreased phosphorylation of GSK3B protein thymoquinone inhibits the reaction [bisphenol A results in decreased phosphorylation of GSK3B protein] Lithium Chloride inhibits the reaction [thymoquinone results in decreased phosphorylation of GSK3B protein]; XAV939 promotes the reaction [thymoquinone results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:32112862 PMID:33315269 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [Cisplatin results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [Thioacetamide results in decreased activity of GSR protein] |
CTD |
PMID:27206696 PMID:30558456 PMID:33832332 PMID:38504479 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] |
CTD |
PMID:35437842 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
thymoquinone results in increased phosphorylation of H2AX protein |
CTD |
PMID:31298468 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Doxorubicin results in increased expression of HIF1A protein] |
CTD |
PMID:34392583 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hk1 |
hexokinase 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Cisplatin results in increased activity of HK1 protein] |
CTD |
PMID:33832332 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [thymoquinone results in increased expression of HMOX1 protein]; [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of HMOX1 protein]; dorsomorphin inhibits the reaction [thymoquinone results in increased expression of HMOX1 protein] thymoquinone results in increased expression of HMOX1 mRNA; thymoquinone results in increased expression of HMOX1 protein |
CTD |
PMID:24355171 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
ISO |
thymoquinone results in decreased expression of HNF1A mRNA |
CTD |
PMID:32112862 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of HSPA5 protein] thymoquinone inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] thymoquinone results in increased expression of HSPA5 mRNA; thymoquinone results in increased expression of HSPA5 protein |
CTD |
PMID:29981725 PMID:34392583 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression |
EXP ISO |
thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IFNG mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IFNG protein] [Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of IFNG protein thymoquinone results in decreased expression of IFNG mRNA; thymoquinone results in decreased expression of IFNG protein |
CTD |
PMID:22450443 PMID:24289642 PMID:26645134 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases expression multiple interactions |
EXP |
thymoquinone results in increased expression of IL10 mRNA; thymoquinone results in increased expression of IL10 protein thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL10 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL10 protein]; thymoquinone inhibits the reaction [Doxorubicin results in decreased expression of IL10 protein]; thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of IL10 mRNA] |
CTD |
PMID:22450443 PMID:25268985 PMID:26645134 PMID:34234489 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Doxorubicin results in increased expression of IL17A protein] |
CTD |
PMID:34392583 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression |
EXP ISO |
thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL1B mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL1B protein]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of IL1B protein] thymoquinone results in increased expression of IL1B protein thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] thymoquinone results in decreased expression of IL1B mRNA; thymoquinone results in decreased expression of IL1B protein |
CTD |
PMID:22450443 PMID:26645134 PMID:29405769 PMID:31935363 PMID:38504479 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
increases expression multiple interactions |
EXP |
thymoquinone results in increased expression of IL4 mRNA; thymoquinone results in increased expression of IL4 protein thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL4 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL4 protein] |
CTD |
PMID:26645134 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL6 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL6 protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; thymoquinone inhibits the reaction [Ethanol results in increased expression of IL6 protein]; thymoquinone inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] Doxorubicin promotes the reaction [thymoquinone results in decreased expression of IL6 protein] thymoquinone results in decreased expression of IL6 mRNA; thymoquinone results in decreased expression of IL6 protein |
CTD |
PMID:22450443 PMID:25268985 PMID:26645134 PMID:29085585 PMID:30558456 PMID:34605108 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of IL6R mRNA Doxorubicin promotes the reaction [thymoquinone results in decreased expression of IL6R mRNA] |
CTD |
PMID:34605108 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of INS1 protein]; thymoquinone inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased secretion of INS1 protein] |
CTD |
PMID:21382363 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions increases expression |
EXP |
thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IRF3 mRNA] thymoquinone results in increased expression of IRF3 mRNA |
CTD |
PMID:29405769 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [bisphenol A results in decreased phosphorylation of IRS1 protein] |
CTD |
PMID:33315269 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions decreases phosphorylation |
ISO |
Doxorubicin promotes the reaction [thymoquinone results in decreased phosphorylation of JAK2 protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased phosphorylation of JAK2 protein] Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of JAK2 protein] |
CTD |
PMID:34605108 PMID:34627931 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Malathion results in increased expression of KIT protein] |
CTD |
PMID:33510276 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Cisplatin results in decreased activity of LAP3 protein] |
CTD |
PMID:33832332 |
|
NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
thymoquinone results in decreased expression of LEF1 mRNA |
CTD |
PMID:32112862 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Bleomycin results in increased expression of LHB protein] |
CTD |
PMID:34818114 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
increases lipidation |
ISO |
thymoquinone results in increased lipidation of MAP1LC3A protein |
CTD |
PMID:31298468 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO |
thymoquinone results in decreased phosphorylation of MAPK1 protein [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [[thymoquinone co-treated with SB 203580] results in increased phosphorylation of MAPK1 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein]; [thymoquinone co-treated with SB 203580] results in increased phosphorylation of MAPK1 protein; Anisomycin promotes the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein]; MAPK3 protein inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:27060453 PMID:34173702 PMID:36176197 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
MAPK14 protein promotes the reaction [[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased cleavage of CASP3 protein]; MAPK14 protein promotes the reaction [[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] |
CTD |
PMID:36176197 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases response to substance increases phosphorylation decreases phosphorylation |
EXP ISO |
thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased phosphorylation of MAPK3 protein] MAPK3 protein results in decreased susceptibility to thymoquinone thymoquinone results in increased phosphorylation of MAPK3 protein [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [[thymoquinone co-treated with SB 203580] results in increased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; [thymoquinone co-treated with SB 203580] results in increased phosphorylation of MAPK3 protein; Anisomycin promotes the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; MAPK3 protein inhibits the reaction [thymoquinone results in increased expression of CASP3 protein modified form]; MAPK3 protein inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein]; MAPK3 protein inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; MAPK3 protein promotes the reaction [[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased expression of MGMT protein]; MAPK3 protein promotes the reaction [[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone]; U 0126 inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein] thymoquinone results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:27060453 PMID:29923357 PMID:34173702 PMID:36176197 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases expression |
ISO |
thymoquinone results in decreased expression of MDM2 protein |
CTD |
PMID:31433961 PMID:34627931 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
decreases expression increases expression |
ISO |
thymoquinone results in decreased expression of MET mRNA thymoquinone results in increased expression of MET mRNA |
CTD |
PMID:31812774 PMID:32112862 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
multiple interactions |
ISO |
[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased expression of MGMT protein; [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [thymoquinone results in decreased expression of MGMT protein]; MAPK3 protein promotes the reaction [[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased expression of MGMT protein] |
CTD |
PMID:36176197 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir125a |
microRNA 125a |
increases expression |
ISO |
thymoquinone results in increased expression of MIR125A mRNA |
CTD |
PMID:34605108 |
|
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
thymoquinone results in decreased expression of MKI67 protein |
CTD |
PMID:31298468 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein] |
CTD |
PMID:27688165 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of MMP2 protein]; pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of MMP2 protein]; thymoquinone results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:27060453 PMID:32112862 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
thymoquinone results in decreased expression of MMP7 mRNA |
CTD |
PMID:32112862 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]; SB 203580 inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]; thymoquinone results in decreased expression of and results in decreased activity of MMP9 protein |
CTD |
PMID:27060453 PMID:32112862 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
decreases activity |
EXP |
thymoquinone results in decreased activity of MPO protein |
CTD |
PMID:22450443 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
thymoquinone results in decreased phosphorylation of MTOR protein |
CTD |
PMID:31298468 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
thymoquinone results in decreased expression of MYC mRNA |
CTD |
PMID:32112862 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
increases expression multiple interactions |
EXP |
thymoquinone results in increased expression of MYD88 mRNA thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of MYD88 mRNA] |
CTD |
PMID:29405769 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nanog |
Nanog homeobox |
decreases expression |
ISO |
thymoquinone results in decreased expression of NANOG protein |
CTD |
PMID:31298468 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nes |
nestin |
decreases expression |
ISO |
thymoquinone results in decreased expression of NES protein |
CTD |
PMID:31298468 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP ISO |
thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of NFE2L2 protein]; thymoquinone inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]; [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]; dorsomorphin inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]; thymoquinone affects the localization of and results in increased activity of NFE2L2 protein |
CTD |
PMID:24355171 PMID:25268985 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Propylthiouracil results in increased expression of NFKB1 mRNA] |
CTD |
PMID:36506574 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [nonylphenol results in increased expression of NGF protein] |
CTD |
PMID:37466128 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in decreased expression of NOS1 protein] |
CTD |
PMID:35940283 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of NOS2 protein] |
CTD |
PMID:38504479 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in increased expression of NOS3 protein] |
CTD |
PMID:35940283 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions |
ISO |
[cordycepin co-treated with thymoquinone] results in decreased expression of NOTCH1 protein |
CTD |
PMID:35774120 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Doxorubicin results in increased expression of NOX4 protein] |
CTD |
PMID:25268985 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in decreased secretion of NPPA protein] |
CTD |
PMID:35940283 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in decreased secretion of NPPB protein modified form] |
CTD |
PMID:35940283 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage increases expression multiple interactions |
ISO |
thymoquinone results in increased cleavage of PARP1 protein thymoquinone results in increased expression of PARP1 protein modified form 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of PARP1 protein modified form]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [thymoquinone results in increased activity of PARP1 protein]; DDIT3 protein affects the reaction [thymoquinone results in increased cleavage of PARP1 protein] |
CTD |
PMID:29981725 PMID:31298468 PMID:31433961 PMID:34627931 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP ISO |
thymoquinone inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in increased expression of PCNA mRNA] thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased expression of PCNA protein] |
CTD |
PMID:29923357 PMID:36193556 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
thymoquinone results in decreased expression of POU5F1 protein |
CTD |
PMID:31298468 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
thymoquinone results in increased expression of PPARG protein PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein]; thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] |
CTD |
PMID:27688165 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein] |
CTD |
PMID:27688165 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of PTEN protein] |
CTD |
PMID:36193556 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
[thymoquinone co-treated with Diclofenac] results in decreased expression of PTGS1 protein |
CTD |
PMID:32220568 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Rbfox3 |
RNA binding fox-1 homolog 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [nonylphenol results in decreased expression of RBFOX3 protein] |
CTD |
PMID:37466128 |
|
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Bleomycin results in increased expression of RELA protein]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of RELA mRNA] |
CTD |
PMID:22982510 PMID:26645134 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in increased expression of RIPK1 protein] |
CTD |
PMID:35940283 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in increased expression of RIPK3 protein] |
CTD |
PMID:35940283 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases expression |
ISO |
thymoquinone results in increased expression of RORC mRNA |
CTD |
PMID:31812774 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Sftpb |
surfactant protein B |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Malathion results in decreased expression of SFTPB mRNA] |
CTD |
PMID:33510276 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO EXP |
thymoquinone inhibits the reaction [Ethanol results in decreased expression of SIRT1 protein] thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of SIRT1 mRNA]; thymoquinone inhibits the reaction [Propylthiouracil results in decreased expression of SIRT1 protein] thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein] |
CTD |
PMID:27688165 PMID:36506574 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of SMAD3 mRNA] |
CTD |
PMID:38504479 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of SMAD7 mRNA] |
CTD |
PMID:38504479 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of SNAI1 protein pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of SNAI1 protein]; SB 203580 inhibits the reaction [thymoquinone results in decreased expression of SNAI1 protein]; thymoquinone promotes the reaction [cordycepin results in decreased expression of SNAI1 protein] |
CTD |
PMID:27060453 PMID:35774120 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions decreases expression |
ISO |
thymoquinone promotes the reaction [cordycepin results in decreased expression of SNAI2 protein] thymoquinone results in decreased expression of SNAI2 protein |
CTD |
PMID:35774120 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP ISO |
thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SOD1 mRNA] thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased activity of SOD1 protein] |
CTD |
PMID:28734741 PMID:36193556 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SOD2 mRNA] |
CTD |
PMID:28734741 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SOD3 mRNA] |
CTD |
PMID:28734741 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
decreases phosphorylation multiple interactions |
ISO |
thymoquinone results in decreased phosphorylation of SRC protein Doxorubicin promotes the reaction [thymoquinone results in decreased phosphorylation of SRC protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased phosphorylation of SRC protein] Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of SRC protein] |
CTD |
PMID:31433961 PMID:34605108 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of STAT3 protein]; thymoquinone results in decreased phosphorylation of and results in decreased activity of STAT3 protein Doxorubicin promotes the reaction [thymoquinone results in decreased phosphorylation of STAT3 protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:31433961 PMID:34605108 PMID:34627931 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
increases expression |
ISO |
thymoquinone results in increased expression of STAT6 mRNA |
CTD |
PMID:31812774 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Stk11 |
serine/threonine kinase 11 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Ethanol results in decreased expression of STK11 protein modified form]; thymoquinone inhibits the reaction [Ethanol results in decreased expression of STK11 protein] thymoquinone inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein] |
CTD |
PMID:27688165 |
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]; thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein] |
CTD |
PMID:27375216 PMID:27688165 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of TGFB1I1 mRNA] |
CTD |
PMID:38504479 |
|
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
increases expression multiple interactions |
EXP |
thymoquinone results in increased expression of TICAM1 mRNA thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TICAM1 mRNA] |
CTD |
PMID:29405769 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
ISO |
thymoquinone inhibits the reaction [Thioacetamide results in increased expression of TIMP1 mRNA]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of TIMP1 protein] pyrazolanthrone inhibits the reaction [thymoquinone results in increased expression of TIMP1 protein]; SB 203580 inhibits the reaction [thymoquinone results in increased expression of TIMP1 protein]; thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TIMP1 protein]; thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein] |
CTD |
PMID:27060453 PMID:27688165 PMID:31935363 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression multiple interactions |
ISO |
thymoquinone results in increased expression of TIMP2 protein pyrazolanthrone inhibits the reaction [thymoquinone results in increased expression of TIMP2 protein]; SB 203580 inhibits the reaction [thymoquinone results in increased expression of TIMP2 protein] |
CTD |
PMID:27060453 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tlr2 |
toll-like receptor 2 |
multiple interactions increases expression |
EXP |
thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR2 mRNA] thymoquinone results in increased expression of TLR2 mRNA |
CTD |
PMID:29405769 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions increases expression |
ISO EXP |
thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] thymoquinone results in increased expression of TLR4 mRNA thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR4 mRNA] |
CTD |
PMID:29405769 PMID:31935363 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression decreases expression |
EXP |
thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; thymoquinone inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of TNF mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of TNF protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; thymoquinone inhibits the reaction [Ethanol results in increased expression of TNF protein]; thymoquinone inhibits the reaction [Propylthiouracil results in increased expression of TNF mRNA]; thymoquinone inhibits the reaction [Propylthiouracil results in increased expression of TNF protein]; thymoquinone inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of TNF protein] thymoquinone results in increased expression of TNF protein thymoquinone results in decreased expression of TNF mRNA; thymoquinone results in decreased expression of TNF protein |
CTD |
PMID:20957680 PMID:22450443 PMID:25268985 PMID:26645134 PMID:29085585 PMID:29405769 PMID:30558456 PMID:34392583 PMID:36506574 PMID:38504479 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
multiple interactions |
ISO |
[Benzo(a)pyrene co-treated with thymoquinone] results in increased expression of TNFRSF10A mRNA |
CTD |
PMID:24289642 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tnfrsf25 |
TNF receptor superfamily member 25 |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein] |
CTD |
PMID:31935363 |
|
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
|
|
G |
Tnni3 |
troponin I3, cardiac type |
multiple interactions |
EXP |
thymoquinone inhibits the reaction [Isoproterenol results in increased secretion of TNNI3 protein] |
CTD |
PMID:35940283 |
|
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
|
|
G |
Top2a |
DNA topoisomerase II alpha |
affects activity |
ISO |
thymoquinone affects the activity of TOP2A protein |
CTD |
PMID:24650156 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of TP53 protein] thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of TP53 protein] |
CTD |
PMID:21609759 PMID:31433961 PMID:34627931 PMID:36193556 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
multiple interactions decreases expression |
ISO |
pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of TWIST1 protein]; SB 203580 inhibits the reaction [thymoquinone results in decreased expression of TWIST1 protein]; thymoquinone promotes the reaction [cordycepin results in decreased expression of TWIST1 protein] |
CTD |
PMID:27060453 PMID:35774120 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO |
Doxorubicin promotes the reaction [thymoquinone results in decreased expression of VEGFA protein]; thymoquinone inhibits the reaction [Doxorubicin results in increased expression of VEGFA protein] |
CTD |
PMID:34605108 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions decreases expression |
ISO |
CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of VIM protein]; Lithium Chloride inhibits the reaction [thymoquinone results in decreased expression of VIM protein]; pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of VIM protein]; XAV939 promotes the reaction [thymoquinone results in decreased expression of VIM protein] |
CTD |
PMID:27060453 PMID:32112862 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wnt3a |
Wnt family member 3A |
decreases expression |
ISO |
thymoquinone results in decreased expression of WNT3A protein |
CTD |
PMID:32112862 |
|
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of XIAP protein] |
CTD |
PMID:31935363 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
decreases expression multiple interactions |
ISO |
thymoquinone results in decreased expression of ZEB1 protein thymoquinone promotes the reaction [cordycepin results in decreased expression of ZEB1 protein] |
CTD |
PMID:35774120 |
|
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
|
|